Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2257 per EA under NDC 67877049990. Its NADAC has been published 411 times since Oct 10, 2018.
FDA first approved this application on Aug 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877049990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209042FDA Approved
8/14/2017
TE Code
AB
On Market Since
8/14/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 411 times since Oct 10, 2018, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $0.7086 (Apr 15, 2020) |
| All-time low | $0.2257 (Aug 19, 2026) |
| 52-week high | $0.2866 |
| 52-week low | $0.2257 |
| Median price | $0.3796 |
| Average price | $0.4114 |
| Largest weekly change | +64.3% (Jul 21, 2021) |
| Weeks tracked | 411 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Ascend Laboratories, LLC, is $0.2257 per EA (NDC 67877049990), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 66.1%. It has been tracked across 411 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Oct 10, 2018, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2257 (Aug 19, 2026) to a high of $0.7086 (Apr 15, 2020), with a median of $0.3796 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 67877049990) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.